MENU
ABOUT US
MAKE A DONATION
Login
SEARCH
CLOSE
Help Center
subscribe
newsletter
Newsstands
Epoch Shop
Gift
TOP NEWS
SPECIAL SERIES
SPECIAL COVERAGE
LATEST ARTICLES
US
US News
US Features
US Politics
US Crime News
New York
San Francisco
Los Angeles
Opinion
Thinking About China
Viewpoints
Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
The Reader’s Turn
China News
US-China Relations
Chinese Regime
Business & Economy
Chinese Culture
China Human Rights
Social Issues
Organ Harvesting in China
World News
Africa News
Americas
Asia & Pacific
Canada
Europe
UK News
Australia News
International
Middle East
Business & Markets
Companies
Economy
Markets
Real Estate
Gold and Commodities
ARTS & CULTURE
Fine Arts & Craftsmanship
Performing Arts
Books
Traditional Culture
Shen Yun Special Coverage
Film & TV
Science
News
Space
Environment
Tech
Tech News
Tech Products & Reviews
Social Media
Sports
Videos
American Thought Leaders
China Insider
Crossroads
Bright
Lifestyle
Inspired
Family & Education
Personal Finance
American Essence
Entertainment
Film & TV
Entertainment News
Health
Experts
Conditions
Life & Wellness
Special Topics
Battlefields
Search Text
SEARCH
EpochTV
US
US Politics
Opinion
World News
China
Hong Kong
Health
Bright
Arts
Falun Gong
Premium
Markets
Games
Livestream
More
Business
CCP Virus
Epoch Fun
Login
All Episodes
Feb 23, 2026
Novo Nordisk Stock Plummets After New Weight-Loss Drug Falls Short Against Rival
Listen
Mary Prenon
The test drug, CagriSema, failed to match Eli Lilly’s Zepbound after an 84-week trial, the company said.
Read Article
Share Link
NEXT EPISODE
Feb 23, 2026
Oman Says 3rd Round of Talks Between US, Iran to Take Place Thursday
Listen
PREVIOUS EPISODE
Feb 23, 2026
FDA Unveils Plan for Quickening Development of Personalized Therapies
Listen
